Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Buprenorphine
Sevodyne
Not routinely available
Local application
24/11/2021

Indication

In adults, for the treatment of chronic non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Restriction: for use in elderly patients (over 65 years).

In adults, for the treatment of chronic non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Restriction: for use in elderly patients (over 65 years).

Therapeutic Area

Central nervous system

Status Description

Not routinely available as local implementation plans are being developed or the ERFC is waiting for further advice from local clinical experts

Formulation

5, 10, 15 and 20 microgram/hour transdermal patch

Comments

November 2021 - Not routinely available as local implementation plans are being developed or the ADTC is waiting for further advice from local clinical experts – decision expected by 02 February 2022.